Loss ofdisrupts lipid signaling and causes slow muscle fiber degeneration.
Key claim: Loss of the lipogenic regulator Srebp1 disrupts lipid mediator signaling and cardiolipin homeostasis, causing selective degeneration of slow oxidative muscle fibers and muscle mass reduction relevant to sarcopenia.
Abstract
, encoding the lipogenic transcription factor SREBP1, has been linked to lean mass by human genomics. We used a CRISPR-Cas9zebrafish knockout combined with LC-MS/MS lipidomics, RNA-seq, Lugol-enhanced micro-CT imaging, and functional assays. Srebp1 loss disrupted slow-fiber organization, increased locomotion in larvae, and reduced muscle mass in adults. This knockout muscle showed altered fatty acid composition, reduced arachidonoylethanolamide (AEA), elevated palmitoylethanolamide (PEA), broad remodeling of polyunsaturated fatty (PUFA) acid-derived mediators, and differential expression of cardiolipin-pathway genes. Integrated transcriptomic-lipidomic analysis revealed-centered connections to myogenic regulators and calcium and lipid signaling, paralleling selective atrophy and loss of slow oxidative fibers under overfeeding and aging. Our data supports a model in which Srebp1 functions as a fiber-type-specific survival checkpoint that maintains lipid compositional and cardiolipin homeostasis, and whose disruption reprograms lipid mediators to drive slow-to-fast fiber switching and slow-fiber degeneration relevant to sarcopenia and sarcopenic obesity.
Why this matters
The finding adds Srebp1-dependent lipid regulation to the causal picture of muscle maintenance: its loss disrupts cardiolipin homeostasis and lipid signaling alongside selective slow oxidative fiber degeneration and muscle-mass reduction [animal-model]. It extends the existing membrane-lipid mechanism without establishing that SREBP1 decline drives ordinary human sarcopenia or that increasing its activity would preserve human muscle [animal-model; human translation unestablished].